40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-72.53%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
-14.74%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
-106.81%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-124.80%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
18.71%
G&A growth while VET reduces overhead. John Neff would investigate operational differences.
No Data
No Data available this quarter, please select a different quarter.
14.29%
Other expenses growth less than half of VET's 100.45%. David Dodd would verify if advantage is sustainable.
11.72%
Operating expenses growth while VET reduces costs. John Neff would investigate differences.
-4.48%
Both companies reducing total costs. Martin Whitman would check industry trends.
-10.42%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-7.68%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-393.95%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-155.64%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-634.78%
Both companies show declining income. Martin Whitman would check industry conditions.
-2046.87%
Both companies show margin pressure. Martin Whitman would check industry conditions.
84.85%
Similar other expenses growth to VET's 97.38%. Walter Schloss would investigate industry patterns.
-828.88%
Pre-tax income decline while VET shows 92.40% growth. Joel Greenblatt would examine position.
-2753.47%
Pre-tax margin decline while VET shows 86.03% growth. Joel Greenblatt would examine position.
110.00%
Tax expense growth 1.25-1.5x VET's 80.72%. Martin Whitman would scrutinize strategy.
-1141.09%
Net income decline while VET shows 94.59% growth. Joel Greenblatt would examine position.
-3890.09%
Net margin decline while VET shows 90.06% growth. Joel Greenblatt would examine position.
-1141.36%
EPS decline while VET shows 94.66% growth. Joel Greenblatt would examine position.
-1141.36%
Diluted EPS decline while VET shows 94.66% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.